| Dr Stephen Norman Bauer, MD | |
|
6501 Coyle Ave, Carmichael, CA 95608-0306 | |
| (916) 537-5275 | |
| Not Available |
| Full Name | Dr Stephen Norman Bauer |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 6501 Coyle Ave, Carmichael, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669442315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | G308900 (California) | Primary |
| Entity Name | Lucent Pathology Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124098736 PECOS PAC ID: 8325087034 Enrollment ID: O20050502000476 |
News Archive
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
Numerous viruses are used in the service of science today. They serve as gene taxis to transfer therapeutic genes into body cells or as therapeutic viruses targeted to infect and destroy cancer cells. For such applications, the viruses are often equipped with additional genes, such as for immune mediators or for proteins inducing programmed cell death. However, these gene products can harm the body if they are released at the wrong moment or at excessive levels.
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing antibody to increase its binding affinity for the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The engineered antibody demonstrates high potency in neutralizing SARS-CoV-2 and preventing infection in animals.
People who survive a heart attack face the greatest risk of dying from sudden cardiac death (SCD) during the first month after leaving the hospital, according to a long-term community study by Mayo Clinic researchers of nearly 3,000 heart attack survivors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Norman Bauer, MD 6501 Coyle Ave, Carmichael, CA 95608-0306 Ph: (916) 537-5275 | Dr Stephen Norman Bauer, MD 6501 Coyle Ave, Carmichael, CA 95608-0306 Ph: (916) 537-5275 |
News Archive
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
Numerous viruses are used in the service of science today. They serve as gene taxis to transfer therapeutic genes into body cells or as therapeutic viruses targeted to infect and destroy cancer cells. For such applications, the viruses are often equipped with additional genes, such as for immune mediators or for proteins inducing programmed cell death. However, these gene products can harm the body if they are released at the wrong moment or at excessive levels.
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing antibody to increase its binding affinity for the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The engineered antibody demonstrates high potency in neutralizing SARS-CoV-2 and preventing infection in animals.
People who survive a heart attack face the greatest risk of dying from sudden cardiac death (SCD) during the first month after leaving the hospital, according to a long-term community study by Mayo Clinic researchers of nearly 3,000 heart attack survivors.
› Verified 7 days ago
Dr. Reggie Zhan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3637 Mission Ave, Suite 5, Carmichael, CA 95608 Phone: 916-863-1496 | |
Dr. Jonathan Edward Musicant, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-537-5275 | |
Pranav Gandhi, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-537-5275 | |
Dr. Larry Lieb, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1921 Lowland Ct, Carmichael, CA 95608 Phone: 916-483-3603 Fax: 916-481-5132 | |
Dr. Daniel Alejandro Cortez, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Dept Of Pathology, Carmichael, CA 95608 Phone: 916-537-5275 Fax: 916-672-1524 | |
Dr. Adina Alexandra Bodolan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Avenue, Carmichael, CA 95608 Phone: 916-860-4460 | |
Alejandro Saropdas Mendoza, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Mercy San Juan Medical Center, 6501 Coyle Avenue, Carmichael, CA 95608 Phone: 916-778-8999 Fax: 916-672-1524 |